These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24596079)

  • 41. Nε-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance.
    Gaens KH; Goossens GH; Niessen PM; van Greevenbroek MM; van der Kallen CJ; Niessen HW; Rensen SS; Buurman WA; Greve JW; Blaak EE; van Zandvoort MA; Bierhaus A; Stehouwer CD; Schalkwijk CG
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1199-208. PubMed ID: 24723555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fatty acid-gene interactions, adipokines and obesity.
    Stryjecki C; Mutch DM
    Eur J Clin Nutr; 2011 Mar; 65(3):285-97. PubMed ID: 21224869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic variation in the vaspin gene affects circulating serum vaspin concentrations.
    Breitfeld J; Tönjes A; Böttcher Y; Schleinitz D; Wiele N; Marzi C; Brockhaus C; Rathmann W; Huth C; Grallert H; Illig T; Blüher M; Kovacs P; Stumvoll M
    Int J Obes (Lond); 2013 Jun; 37(6):861-6. PubMed ID: 22907691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
    Kravchun P; Kadykova O; Gabisoniia T
    Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
    Stefanović V; Antić S
    Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum.
    Gkiomisi A; Makedou KG; Anastasilakis AD; Polyzos SA; Kourtis A; Gerou S; Gavana E; Dagklis T; Rousso D; Giannoulis C
    Cytokine; 2013 Jan; 61(1):127-32. PubMed ID: 23041430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ.
    Calabro P; Yeh ET
    Subcell Biochem; 2007; 42():63-91. PubMed ID: 17612046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation?
    Sell H; Eckel J
    Proc Nutr Soc; 2009 Nov; 68(4):378-84. PubMed ID: 19698204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cross-talk between adipose tissue and vasculature: role of adiponectin.
    Li FY; Cheng KK; Lam KS; Vanhoutte PM; Xu A
    Acta Physiol (Oxf); 2011 Sep; 203(1):167-80. PubMed ID: 21062420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin.
    Piya MK; McTernan PG; Kumar S
    J Endocrinol; 2013 Jan; 216(1):T1-T15. PubMed ID: 23160966
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Higher vaspin levels in subjects with obesity and type 2 diabetes mellitus: a meta-analysis.
    Feng R; Li Y; Wang C; Luo C; Liu L; Chuo F; Li Q; Sun C
    Diabetes Res Clin Pract; 2014 Oct; 106(1):88-94. PubMed ID: 25151227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Basic Residues of β-Sheet A Contribute to Heparin Binding and Activation of Vaspin (Serpin A12).
    Ulbricht D; Oertwig K; Arnsburg K; Saalbach A; Pippel J; Sträter N; Heiker JT
    J Biol Chem; 2017 Jan; 292(3):994-1004. PubMed ID: 27941022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional and structural features of adipokine family.
    Raucci R; Rusolo F; Sharma A; Colonna G; Castello G; Costantini S
    Cytokine; 2013 Jan; 61(1):1-14. PubMed ID: 23022179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Could Vaspin Be a Potential Diagnostic Marker in Endometrial Cancer?
    Pietrzyk D; Tkacz P; Kozłowski M; Kwiatkowski S; Rychlicka M; Pius-Sadowska E; Machaliński B; Cymbaluk-Płoska A
    Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Obesity and thyroid cancer.
    Marcello MA; Cunha LL; Batista FA; Ward LS
    Endocr Relat Cancer; 2014 Oct; 21(5):T255-71. PubMed ID: 24741026
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of the novel adipokines vaspin and omentin in chronic inflammatory diseases.
    Radzik-Zając J; Wytrychowski K; Wiśniewski A; Barg W
    Pediatr Endocrinol Diabetes Metab; 2023; 29(1):48-52. PubMed ID: 36734393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intron specific polymorphic site of vaspin gene along with vaspin circulatory levels can influence pathophysiology of type 2 diabetes.
    Rathwa N; Parmar N; Palit SP; Patel R; Ramachandran AV; Begum R
    Life Sci; 2020 Feb; 243():117285. PubMed ID: 31926241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaspin promotes insulin sensitivity of elderly muscle and is upregulated in obesity.
    Nicholson T; Church C; Tsintzas K; Jones R; Breen L; Davis ET; Baker DJ; Jones SW
    J Endocrinol; 2019 Feb; ():. PubMed ID: 30721136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of a rare functional truncating mutation rs61757459 in vaspin (SERPINA12) on circulating vaspin levels.
    Breitfeld J; Heiker JT; Böttcher Y; Schleinitz D; Tönjes A; Weidle K; Krause K; Kuettner EB; Scholz M; Kiess W; Sträter N; Beck-Sickinger AG; Stumvoll M; Körner A; Blüher M; Kovacs P
    J Mol Med (Berl); 2013 Nov; 91(11):1285-92. PubMed ID: 23756768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of vaspin in human eating behaviour.
    Breitfeld J; Tönjes A; Gast MT; Schleinitz D; Blüher M; Stumvoll M; Kovacs P; Böttcher Y
    PLoS One; 2013; 8(1):e54140. PubMed ID: 23342091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.